YOLANDA MAGANA-CAMACHO: Open Payments
NPI 1558758714 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 15 payments from 11 companies in 2025. Trend: 2023 $498 · 2024 $997 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $250 |
| ViiV Healthcare Company | 2 | $219 |
| Amgen Inc. | 2 | $198 |
| Abbott Laboratories | 1 | $146 |
| Exact Sciences Corporation | 2 | $134 |
| Braeburn Inc. | 1 | $126 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Verrica Pharmaceuticals Inc. | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Medtronic, Inc. | 1 | $19 |
Products named: FREESTYLE LIBRE 3, BRIXADI, Ozempic, APRETUDE, Wegovy, AIRSUPRA, YCANTH, DUPIXENT.
Industry payments across CA — which companies pay providers there.
